A novel cationized agarose-based oral mucoadhesive delivery platform
Ars Pharmaceutica (Internet) · 20.06.2026 · 67 (3) · 299-315
DOI: 10.30827/ars.v67i3.36138 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ars Pharmaceutica (Internet), online erschienen am 20.06.2026. Verfasst von Angeles Gloria Rodríguez-Basso und 6 weiteren Autor:innen. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Introduction
Gallic acid has demonstrated benefits in intestinal inflammatory diseases but exhibits disadvantageous oral pharmacokinetics. This study aims to characterize a novel polyelectrolyte-drug complex involving gallic acid, designed for oral administration to target the intestinal tract.
Methods
The agarose was cationized, complexed with gallic acid and characterized by infrared spectroscopy, nuclear magnetic resonance, scanning electron microscopy and high performance liquid chromatography. Mucoadhesivity, in vitro and in vivo release were also assessed. The antinociceptive activity was measured.
Results
The concentration of gallic acid in the complex was 189.8 ± 1.1 µg/mg. The formulation showed a greater mucoadhesive capacity in normal colon (37.4 ± 2.2 %) and jejunum (24.4 ± 2.5 %) and in damaged colon (139.3 ± 0.9 %), jejunum (24.9 ± 1.4 %), and ileum (17.5 ± 1.6 %). However, the complex decreased its adhesion in the normal stomach (20.8 ± 1.4 %), without any changes in injured stomach and normal ileum. Additionally, in vitro release test increased the release time at pH 6.0 and 7.4 compared with the unformulated compound in the same conditions. In vivo analysis showed improved pharmacokinetic behavior with the complex, meanwhile antinociception activity of gallic acid was preserved.
Conclusions
This oral mucoadhesive system improves the pharmacokinetic behavior of gallic acid and preserves its biological activity, positioning it as a useful strategy for the treatment of intestinal disorders.
Zitieren
APA
Rodríguez-Basso, A. G., Prado, H. J., Matulewicz, M. C., Bonafede, S. L., Vitali, V. A., Fuda, J. A., & Gorzalczany, S. B. (2026). A novel cationized agarose-based oral mucoadhesive delivery platform. Ars Pharmaceutica (Internet), 67(3), 299-315. https://doi.org/10.30827/ars.v67i3.36138
Vancouver
Rodríguez-Basso AG, Prado HJ, Matulewicz MC, Bonafede SL, Vitali VA, Fuda JA, et al. A novel cationized agarose-based oral mucoadhesive delivery platform. Ars Pharmaceutica (Internet). 2026;67(3):299-315. doi:10.30827/ars.v67i3.36138
BibTeX
@article{RodrguezBasso2026,
author = {Rodríguez-Basso, Angeles Gloria and Prado, Héctor Juan and Matulewicz, María Cristina and Bonafede, Silvina Laura and Vitali, Victoria Andrea and Fuda, Julián Andrés and Gorzalczany, Susana Beatriz},
title = {A novel cationized agarose-based oral mucoadhesive delivery platform},
journal = {Ars Pharmaceutica (Internet)},
year = {2026},
volume = {67},
number = {3},
pages = {299--315},
doi = {10.30827/ars.v67i3.36138}
}
EUVIMED